Literature DB >> 21725603

Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.

Charn-Jung Chang1, Chuan-Chih Hsu, Chin-Hong Chang, Lo-Lin Tsai, Yu-Chao Chang, Shao-Wei Lu, Cuuan-Hang Yu, Hsu-Shan Huang, Jhi-Joung Wang, Chung-Hung Tsai, Ming-Yung Chou, Cheng-Chia Yu, Fang-Wei Hu.   

Abstract

Oral squamous cell carcinoma (OSCC) is a prevalent cancer worldwide. Let-7 family has been shown to function as a tumor suppressor through regulating multiple oncogenic signaling. Recent study reported that combined underexpression of miR-205 and let-7d showed negative correlation with the survival prognosis of head and neck cancer patients. However, the let-7d-involved mechanism in regulating OSCC is still unclear. In this study, we first demonstrated that let-7d expression was significantly decreased while Twist and Snail expression was increased in OSCC cancer cell lines and primary cultures as compared to normal human oral keratinocyte cells. To further investigate the role of let-7d in OSCC, we applied the SPONGE method to knock down let-7d in OECM-1 and two primary OSCC cell types. The results showed that knockdown of let-7d promote epithelial-mesenchymal transition (EMT) traits and migratory/invasive capabilities in OSCC cells. Furthermore, down-expression of let-7d significantly activated Twist and Snail expressions and chemo-resistant abilities of OSCC cells. Notably, overexpression of let-7d effectively reversed the EMT phenotype, blocked migratory/invasive abilities, and further increased the chemosensitivity in oral cancer tumor initiating ALDH1+ cells. In sum, these results show that let-7d negatively modulates EMT expression and also plays a role in regulating chemo-resistant ability in oral cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725603     DOI: 10.3892/or.2011.1360

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  67 in total

1.  RAC1 activation mediates Twist1-induced cancer cell migration.

Authors:  Wen-Hao Yang; Hsin-Yi Lan; Chi-Hung Huang; Shyh-Kuan Tai; Cheng-Hwai Tzeng; Shou-Yen Kao; Kou-Juey Wu; Mien-Chie Hung; Muh-Hwa Yang
Journal:  Nat Cell Biol       Date:  2012-03-11       Impact factor: 28.824

2.  SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors.

Authors:  Flavio Cimadamore; Alejandro Amador-Arjona; Connie Chen; Chun-Teng Huang; Alexey V Terskikh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-24       Impact factor: 11.205

Review 3.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

Review 4.  Microenvironmental regulation of cancer metastasis by miRNAs.

Authors:  Yun Zhang; Pengyuan Yang; Xiao-Fan Wang
Journal:  Trends Cell Biol       Date:  2013-10-11       Impact factor: 20.808

5.  MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.

Authors:  Ankana Tiwari; Swamy Shivananda; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

Review 6.  The role of microRNAs in myopia.

Authors:  Bo Jiang; Yanan Huo; Yangshun Gu; Jianyong Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-11       Impact factor: 3.117

Review 7.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

8.  Extracellular microRNA signature in chronic kidney disease.

Authors:  Jagdeesan Muralidharan; Ali Ramezani; Monica Hubal; Susan Knoblach; Shashi Shrivastav; Sara Karandish; Richard Scott; Nirmal Maxwell; Savas Ozturk; Srinivasan Beddhu; Jeffrey B Kopp; Dominic S Raj
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-11

Review 9.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

10.  Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.

Authors:  Eoin P Brennan; Karen A Nolan; Emma Börgeson; Oisín S Gough; Caitríona M McEvoy; Neil G Docherty; Debra F Higgins; Madeline Murphy; Denise M Sadlier; Syed Tasadaque Ali-Shah; Patrick J Guiry; David A Savage; Alexander P Maxwell; Finian Martin; Catherine Godson
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.